• About
  • Team
  • funds
    • o2h human health KI EIS
    • o2h human health SEIS
    • o2h human health EIS
  • Portfolio
  • Documents
  • news
    • Press releases
    • Blog
    • Press Coverage
    • Events
  • Contact
  • login

o2h-ventures

  • About
  • Team
  • funds
    • o2h human health KI EIS
    • o2h human health SEIS
    • o2h human health EIS
  • Portfolio
  • Documents
  • news
    • Press releases
    • Blog
    • Press Coverage
    • Events
  • Contact
  • login
29 Jul 2019
Watch o2h ventures CEO Sunil Shah feature in the British Business Bank Finance Guide video
Connect with us
  • linkedin
  • twitter
  • instagram
  • facebook
  • youtube

Archives

  • Watch o2h ventures CEO Sunil Shah feature in the British Business Bank Finance Guide video 29 July, 2019
  • Q&A with Angel Investor Sunil Shah | The Sunday Times 15 July, 2019
  • Metrion Biosciences Closes Funding Round- o2h ventures 2 July, 2019
o2h-ventures
The o2h team are leaders in the biotech community and have been actively involved as investors, holding various board/industry positions as well as being engaged in grassroots scientific activity for over 20 years.
Useful Links
  • About Us
  • Blog
  • Documents Centre
  • Contact Us
  • Team
News
  • Sunil Shah, CEO of o2h ventures, wins the Cambridge Independent Science and Technology Awards as CEO of the Year
  • University of Sussex and o2h Ventures Announce Creation and Investment in Stingray Bio, a Company for New Oncology Drugs Targeting the LMTK3 Kinase Pathway
  • The o2h human health S/EIS flagship fund – Fully Deployed
Connect with us
  • linkedin
  • twitter
  • instagram
  • facebook
© 2021 o2h ventures
  • Privacy Policy
  • Blog
  • Contact us
o2h ventures Limited is regulated and authorised by the Financial Conduct Authority (FRN 812245). Capital at risk, only suitable for high net worth and sophisticated investors